TEVA 22 10 (Sucralfate 1 g)
Pill imprint TEVA 22 10 has been identified as Sucralfate 1 g.
Sucralfate is used in the treatment of gerd; stomatitis; stomach ulcer; duodenal ulcer; hyperphosphatemia of renal failure (and more), and belongs to the drug class miscellaneous GI agents. There is no proven risk in humans during pregnancy. Sucralfate 1 g is not subject to the Controlled Substances Act.
See also related documents.
Images for TEVA 22 10 (Sucralfate 1 g)
Sucralfate
- Imprint:
-
TEVA
22 10 - Strength:
- 1 g
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous GI agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-2210
More resources
Sucralfate is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
